2013/2903(DEA)
Exemption for lead acetate markers for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment
Basic information
2013/2903(DEA)
DEA - Delegated acts procedure
Supplementing 2008/0240(COD)
Subject
3.40.06 Electronics, electrotechnical industries, ICT, robotics
3.70.13 Dangerous substances, toxic and radioactive wastes (storage, transport)
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed ENVIEnvironment, Public Health and Food Safety
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 18/10/2013 | Non-legislative basic document published | C(2013)06794 | |
| 18/10/2013 | Initial period for examining delegated act 2.0 month(s) | ||
| 23/10/2013 | Committee referral announced in Parliament | ||
| 19/12/2013 | Delegated act not objected by Council | ||
| 07/01/2014 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2013/2903(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 2008/0240(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/7/14362
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2013)06794 18/10/2013